Skip to content

RCT of Home-based vs Formal Physical Therapy for Treatment of New Onset Non-insertional Achilles Tendinopathy

Randomized Controlled Trial of Home-based Versus Formal Physical Therapy for Treatment of New Onset Non-insertional Achilles Tendinopathy

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06374654
Enrollment
56
Registered
2024-04-18
Start date
2025-07-01
Completion date
2027-07-03
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles Tendinopathy

Brief summary

The goal of this prospective randomized controlled trial is to compare the effectiveness of a home-based exercise protocol to formal physical therapy in patients who have been diagnosed with Achilles tendinopathy. The null hypothesis is that there will be no difference in the treatment outcomes between patients with Achilles tendinopathy who participate in a home-based program versus patients with Achilles tendinopathy who undergo formal physical therapy. Participants will be randomized to a 12-week home-based or formal physical therapy protocol and asked to complete brief outcomes surveys at their initial visit, and at 6 weeks, 12 weeks, 6 months, and 1 year after their initial visit.

Interventions

OTHERHome-based Exercise Protocol

The home-based eccentric exercise protocol is a do-as-tolerated variation on the protocol described by Alfredson et al. in 1998. The protocol includes doing a series of heel raises, twice daily. No equipment is necessary. Patients will be given handouts and video links that depict and describe the exercises and their prescribed frequency.

Patients will be given a prescription for physical therapy consisting of 1-2 sessions per week for 6 weeks, with a renewal for another 6 weeks to be executed at the physical therapists' discretion. If an in-person visit is necessary for the renewal, or is requested by the physical therapist, the patient will be seen again in the office. Each patient will be given a release form to provide to his or her physical therapist. The release form will request a written record of all the treatment methods used by the physical therapist. Physical therapists who participate in the care of patients in this study will treat each patient using any and all methods that their professional experience deems clinically necessary.

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Must be 18 years of age * Must have a new diagnosis of Achilles tendinopathy that has presented with pain, thickening and tenderness at the mid substance of the Achilles tendon * Symptoms present for at least 6 weeks

Exclusion criteria

* Patients with insertional Achilles pain or tenderness or concomitant plantar foot pain * Patients who have had prior treatment with home eccentric stretching or physical therapy * Patients who have prior diagnosis and treatment for Achilles tendinopathy * Patients with history of injection (corticosteroid or sclerosing agents) to the Achilles tendon * Patients with inflammatory arthritis * Recent fluoroquinolone antibiotics (these agents are known to alter Achilles tendon physiology) * Patients who have had prior foot or ankle surgery * Individuals that do not speak English * Bilateral disease * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Victorian Institute of Sports Assessment self-administered Achilles questionnaire (VISA-A)Initial presentation, 6 weeks, 12 weeks, 6 months, and one year from the start of treatmentAchilles tendon-specific questionnaire that asks about patient pain, functional status, and activity level.

Secondary

MeasureTime frame
PROMIS Pain Interference (4a)Initial presentation, 6 weeks, 12 weeks, 6 months, and one year from the start of treatment
PROMIS Pain Intensity (3a)Initial presentation, 6 weeks, 12 weeks, 6 months, and one year from the start of treatment
PROMIS Depression (4a)Initial presentation, 6 weeks, 12 weeks, 6 months, and one year from the start of treatment
Patient Acceptable Symptom State QuestionnaireInitial presentation, 6 weeks, 12 weeks, 6 months, and one year from the start of treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026